Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nadine Piecha"'
Autor:
Teodora Nikolova, Bernd Kaina, Kerstin Borgmann, Mengwan Wang, Nadine Piecha, Andrea Piée-Staffa, Nancy Berte
Structures of CCNU and HR inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd7ea25c69df8cabfa5b66788ba6249
https://doi.org/10.1158/1535-7163.22506594
https://doi.org/10.1158/1535-7163.22506594
Autor:
Teodora Nikolova, Bernd Kaina, Kerstin Borgmann, Mengwan Wang, Nadine Piecha, Andrea Piée-Staffa, Nancy Berte
Malignant gliomas exhibit a high level of intrinsic and acquired drug resistance and have a dismal prognosis. First- and second-line therapeutics for glioblastomas are alkylating agents, including the chloroethylating nitrosoureas (CNU) lomustine, ni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fce105862f01cb99f2b33a6059b2ad7
https://doi.org/10.1158/1535-7163.c.6538440.v1
https://doi.org/10.1158/1535-7163.c.6538440.v1
Autor:
Teodora Nikolova, Bernd Kaina, Kerstin Borgmann, Mengwan Wang, Nadine Piecha, Andrea Piée-Staffa, Nancy Berte
Representative images of γH2AX foci 6 h after CCNU treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcad97ff89e91a489d54a75eff46c9d
https://doi.org/10.1158/1535-7163.22506591
https://doi.org/10.1158/1535-7163.22506591
Autor:
Teodora Nikolova, Bernd Kaina, Kerstin Borgmann, Mengwan Wang, Nadine Piecha, Andrea Piée-Staffa, Nancy Berte
Effects of CCNU and HRi on transcription in glioblastoma cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cd43091115d9f385d869d75030a52d
https://doi.org/10.1158/1535-7163.22506588.v1
https://doi.org/10.1158/1535-7163.22506588.v1
Autor:
Bernd Kaina, Nancy Berte, Mengwan Wang, Kerstin Borgmann, Theodora Nikolova, Andrea Piee-Staffa, Nadine Piecha
Publikováno v:
Molecular Cancer Therapeutics. 15:2665-2678
Malignant gliomas exhibit a high level of intrinsic and acquired drug resistance and have a dismal prognosis. First- and second-line therapeutics for glioblastomas are alkylating agents, including the chloroethylating nitrosoureas (CNU) lomustine, ni